Ivabradine did not reduce the occurrence of myocardial injury after noncardiac surgery (MINS), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025. MINS is a ...
Patients with postural orthostatic tachycardia syndrome treated with ivabradine have better heart-rate control when standing. HealthDay News — Ivabradine lowers heart rate (HR) and relieves symptoms ...
(HealthDay News) — For patients with angina pectoris, ivabradine is associated with improvements in certain parameters of quality of life (QoL), according to a study published online in Circulation: ...
Please provide your email address to receive an email when new articles are posted on . Initiating ivabradine before discharge among patients with stabilized HF increased ivabradine use at 180 days ...
Ivabradine is a novel agent that lowers heart rate by inhibiting the I(f) current in the sinoatrial node. The SHIFT trial evaluated the drug’s efficacy in 6,558 patients with symptomatic chronic heart ...
SILVER SPRING, MD — Response to the recent approval of the heart-rate–slowing drug ivabradine (Corlanor, Amgen) by the US Food and Drug Administration (FDA) has included cautious enthusiasm as well as ...
THOUSAND OAKS, Calif., Aug. 27, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the U.S. Food and Drug Administration (FDA) has granted priority review designation for ivabradine for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results